Trials / Completed
CompletedNCT00502073
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sirion Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cyclosporine |
Timeline
- First posted
- 2007-07-17
- Last updated
- 2011-07-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00502073. Inclusion in this directory is not an endorsement.